Injective Labs

Injective Labs is a research and development company and one of the core contributors to Injective, a layer-1 blockchain built for finance with smart contracts and interoperability with Ethereum, Solana and Cosmos. Its products include the Helix decentralized orderbook exchange for crypto assets and derivatives, Mito, a DeFi protocol with strategy vaults and a token launchpad, and validator nodes it operates for Web3 projects.

Its users are crypto traders on Helix, developers building on Injective, and Web3 projects that use its validator node operation. The company's website does not describe its revenue model. Press items on the site include Google Cloud and Deutsche Telekom running Injective validators, and Canary Capital's filings for a staked Injective ETF.

The website states that the team has 52 people across 20 countries and lists a New York office, with remote work also offered. Open roles include mobile, protocol, front-end and product positions, a quant researcher, a paralegal and a product designer. The website does not give a founding year.

Product: Injective layer-1 blockchain for finance, Helix decentralized orderbook exchange, Mito DeFi protocol, and validator node operation.